In the year 2023, Zhejiang RIVITA Biotech Co., Ltd actively participated in global professional exhibitions in the first year following the end of the COVID-19 pandemic. Through these exhibitions, we engaged in friendly exchanges and collaborative reviews with many old friends and clients. Additionally, we also formed acquaintances with numerous new friends and clients. Throughout the exhibition period, we comprehensively elaborated on the current market dynamics and prospects with these new and existing contacts. Leveraging RIVITA‘s nearly 20 years of industry experience and our understanding of the latest market trends, we engaged in open, forward-looking, and constructive communication with both new and existing clients. This proactive discussion extended to ongoing collaborations and potential opportunities, facilitating a comprehensive advancement of various initiatives.

The Korean market is one of the key markets for our focus on nutrition, pharmaceuticals APIs, cosmetics ingredients, and chemicals. From August 30 to September 1, 2023, we participated as an exhibitor in CPHI Korea. During this exhibition, Zhejiang RIVITA engaged in beneficial discussions and communication with practitioners in the Korean industry, both new and existing clients, as well as industry experts. This allowed us to gain a deeper understanding of the industry dynamics and market evolution in the Korean market.

 RIVITA also actively shared insights, taking into account China’s market, the company’s own supply chain resources, and industry knowledge. We aim to contribute positively to the Korean market by leveraging our expertise. We are committed to actively participating in the Korean market, contributing our strengths to relevant industries, and making a positive impact on those sectors.